» Articles » PMID: 35563976

Inverse Molecular Docking Elucidating the Anticarcinogenic Potential of the Hop Natural Product Xanthohumol and Its Metabolites

Overview
Journal Foods
Specialty Biotechnology
Date 2022 May 14
PMID 35563976
Authors
Affiliations
Soon will be listed here.
Abstract

Natural products from plants exert a promising potential to act as antioxidants, antimicrobials, anti-inflammatory, and anticarcinogenic agents. Xanthohumol, a natural compound from hops, is indeed known for its anticarcinogenic properties. Xanthohumol is converted into three metabolites: isoxanthohumol (non-enzymatically) as well as 8- and 6-prenylnaringenin (enzymatically). An inverse molecular docking approach was applied to xanthohumol and its three metabolites to discern their potential protein targets. The aim of our study was to disclose the potential protein targets of xanthohumol and its metabolites in order to expound on the potential anticarcinogenic mechanisms of xanthohumol based on the found target proteins. The investigated compounds were docked into the predicted binding sites of all human protein structures from the Protein Data Bank, and the best docking poses were examined. Top scoring human protein targets with successfully docked compounds were identified, and their experimental connection with the anticarcinogenic function or cancer was investigated. The obtained results were carefully checked against the existing experimental findings from the scientific literature as well as further validated using retrospective metrics. More than half of the human protein targets of xanthohumol with the highest docking scores have already been connected with the anticarcinogenic function, and four of them (including two important representatives of the matrix metalloproteinase family, MMP-2 and MMP-9) also have a known experimental correlation with xanthohumol. Another important protein target is acyl-protein thioesterase 2, to which xanthohumol, isoxanthohumol, and 6-prenylnaringenin were successfully docked with the lowest docking scores. Moreover, the results for the metabolites show that their most promising protein targets are connected with the anticarcinogenic function as well. We firmly believe that our study can help to elucidate the anticarcinogenic mechanisms of xanthohumol and its metabolites as after consumption, all four compounds can be simultaneously present in the organism.

Citing Articles

Mechanism of Action and Therapeutic Potential of Xanthohumol in Prevention of Selected Neurodegenerative Diseases.

Dlugosz A, Blaszak B, Czarnecki D, Szulc J Molecules. 2025; 30(3).

PMID: 39942798 PMC: 11821245. DOI: 10.3390/molecules30030694.


A Systematic Review: Quercetin-Secondary Metabolite of the Flavonol Class, with Multiple Health Benefits and Low Bioavailability.

Frent O, Stefan L, Morgovan C, Duteanu N, Dejeu I, Marian E Int J Mol Sci. 2024; 25(22).

PMID: 39596162 PMC: 11594109. DOI: 10.3390/ijms252212091.


Validating Interactions of Pathogenic Proteins of and with Phytochemicals of and .

Zou W, Hassan I, Akram B, Sattar H, Altaf A, Aqib A Microorganisms. 2023; 11(10).

PMID: 37894108 PMC: 10609126. DOI: 10.3390/microorganisms11102450.


Antioxidant Activity of Different Hop ( L.) Genotypes.

Kolenc Z, Hribernik T, Langerholc T, Pintaric M, Prevolnik Povse M, Bren U Plants (Basel). 2023; 12(19).

PMID: 37836176 PMC: 10575397. DOI: 10.3390/plants12193436.


Chemistry, Bioactivity, and Prediction of the Quality Marker (Q-Marker) of Plants in China: A Review.

Bahetjan Y, Muhaxi M, Pang K, Kizaibek M, Tang H, Sefidkon F Molecules. 2023; 28(13).

PMID: 37446853 PMC: 10343754. DOI: 10.3390/molecules28135191.


References
1.
Stern A, Furlan V, Novak M, Stampar M, Kolenc Z, Kores K . Chemoprotective Effects of Xanthohumol against the Carcinogenic Mycotoxin Aflatoxin B1. Foods. 2021; 10(6). PMC: 8230236. DOI: 10.3390/foods10061331. View

2.
Jukic M, Kores K, Janezic D, Bren U . Repurposing of Drugs for SARS-CoV-2 Using Inverse Docking Fingerprints. Front Chem. 2022; 9:757826. PMC: 8748264. DOI: 10.3389/fchem.2021.757826. View

3.
Konc J, Lesnik S, Skrlj B, Janezic D . ProBiS-Dock Database: A Web Server and Interactive Web Repository of Small Ligand-Protein Binding Sites for Drug Design. J Chem Inf Model. 2021; 61(8):4097-4107. DOI: 10.1021/acs.jcim.1c00454. View

4.
Fisher D, Smith J, Pillar J, St Denis S, Cheng J . Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase. J Biol Chem. 1998; 273(25):15559-64. DOI: 10.1074/jbc.273.25.15559. View

5.
Zhao H, Wang J, Tang Q, Mo C, Guo J, Chen T . Functional expression of two NADPH-cytochrome P450 reductases from Siraitia grosvenorii. Int J Biol Macromol. 2018; 120(Pt B):1515-1524. DOI: 10.1016/j.ijbiomac.2018.09.128. View